Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–20.
Louis DN, Giannini C, Capper D, Paulus W, Figarella-Branger D, Lopes MB, et al. cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma. IDH-mutant Acta Neuropathol. 2018;135(4):639–42.
Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB, et al. cIMPACT-NOW update 3: recommended diagnostic criteria for "diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV". Acta Neuropathol. 2018;136(5):805–10.
Article CAS PubMed PubMed Central Google Scholar
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231–51.
Article CAS PubMed PubMed Central Google Scholar
Lasocki A, Anjari M, Ӧrs Kokurcan S, Thust SC. Conventional MRI features of adult diffuse glioma molecular subtypes: a systematic review. Neuroradiology. 2021;63(3):353–62.
Bhandari AP, Liong R, Koppen J, Murthy SV, Lasocki A. Noninvasive determination of IDH and 1p19q status of lower-grade gliomas using MRI Radiomics: a systematic review. AJNR Am J Neuroradiol. 2021;42(1):94–101.
Article CAS PubMed PubMed Central Google Scholar
McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, Clifford T, et al. Preferred reporting items for a systematic review and Meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. Jama. 2018;319(4):388–96.
Lober RM, Cho YJ, Tang Y, Barnes PD, Edwards MS, Vogel H, et al. Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma. J Neuro-Oncol. 2014;117(1):175–82.
Ishibashi K, Inoue T, Fukushima H, Watanabe Y, Iwai Y, Sakamoto H, et al. Pediatric thalamic glioma with H3F3A K27M mutation, which was detected before and after malignant transformation: a case report. Childs Nerv Syst. 2016;32(12):2433–8.
Aboian MS, Solomon DA, Felton E, Mabray MC, Villanueva-Meyer JE, Mueller S, et al. Imaging characteristics of pediatric diffuse midline gliomas with histone H3 K27M mutation. AJNR Am J Neuroradiol. 2017;38(4):795–800.
Article CAS PubMed PubMed Central Google Scholar
Yoshimoto K, Hatae R, Sangatsuda Y, Suzuki SO, Hata N, Akagi Y, et al. Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution. Brain Tumor Pathol. 2017;34(3):103–12.
Lopez GY, Oberheim Bush NA, Phillips JJ, Bouffard JP, Moshel YA, Jaeckle K, et al. Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression. Acta Neuropathol. 2017;134(6):961–3.
Article CAS PubMed PubMed Central Google Scholar
Vettermann FJ, Neumann JE, Suchorska B, Bartenstein P, Giese A, Dorostkar MM, et al. K27M midline gliomas display malignant progression by imaging and histology. Neuropathol Appl Neurobiol. 2017;43(5):458–62.
Article CAS PubMed Google Scholar
Gilbert AR, Zaky W, Gokden M, Fuller CE, Ocal E, Leeds NE, et al. Extending the neuroanatomic territory of diffuse midline glioma, K27M mutant: pineal region origin. Pediatr Neurosurg. 2018;53(1):59–63.
Vettermann FJ, Felsberg J, Reifenberger G, Hasselblatt M, Forbrig R, Berding G, et al. Characterization of diffuse gliomas with histone H3-G34 mutation by MRI and dynamic 18F-FET PET. Clin Nucl Med. 2018;43(12):895–8.
D'Amico RS, Zanazzi G, Wu P, Canoll P, Bruce JN. Pineal region glioblastomas display features of diffuse midline and non-midline gliomas. J Neuro-Oncol. 2018;140(1):63–73.
Daoud EV, Rajaram V, Cai C, Oberle RJ, Martin GR, Raisanen JM, et al. Adult brainstem gliomas with H3K27M mutation: radiology, pathology, and prognosis. J Neuropathol Exp Neurol. 2018;77(4):302–11.
Article CAS PubMed Google Scholar
Dormegny L, Chibbaro S, Ganau M, Santin M, Kremer L, Proust F. Biopsying a spinal cord lesion: a diagnostic dilemma. Case report and review of literature. Neuro-Chirurgie. 2018;64(6):425–30.
Article CAS PubMed Google Scholar
Gao Y, Feng YY, Yu JH, Li QC, Qiu XS, Wang EH. Diffuse midline gliomas with histone H3-K27M mutation: a rare case with PNET-like appearance and neuropil-like islands. Neuropathology. 2018;38(2):165–70.
Article CAS PubMed Google Scholar
Puntonet J, Dangouloff-Ros V, Saffroy R, Pagès M, Andreiuolo F, Grill J, et al. Historadiological correlations in high-grade glioma with the histone 3.3 G34R mutation. J Neuroradiol. 2018;45(5):316–22.
Jung JS, Choi YS, Ahn SS, Yi S, Kim SH, Lee SK. Differentiation between spinal cord diffuse midline glioma with histone H3 K27M mutation and wild type: comparative magnetic resonance imaging. Neuroradiology. 2019;61(3):313–22.
Qiu T, Chanchotisatien A, Qin Z, Wu J, Du Z, Zhang X, et al. Imaging characteristics of adult H3 K27M-mutant gliomas. J Neurosurg. 2019;15:1-9.
He P, Chen W, Qiu XX, Xi YB, Guan H, Xia J. A rare high-grade glioma with a histone H3 K27M mutation in the hypothalamus of an adult patient. World Neurosurg. 2019;128:527–31.
Chanchotisatien A, Pan J, Du Z, Qiu T, Yu J, Chu S. Slow-growing thalamic glioma with histone H3 lysine 27-to-methionine mutation: 3-year follow-up before surgical intervention. World Neurosurg. 2019;127:266–8.
Chen H, Hu W, He H, Yang Y, Wen G, Lv X. Noninvasive assessment of H3 K27M mutational status in diffuse midline gliomas by using apparent diffusion coefficient measurements. Eur J Radiol. 2019;114:152–9.
Aboian MS, Tong E, Solomon DA, Kline C, Gautam A, Vardapetyan A, et al. Diffusion characteristics of pediatric diffuse midline gliomas with histone H3-K27M mutation using apparent diffusion coefficient histogram analysis. AJNR Am J Neuroradiol. 2019;40(11):1804–10.
CAS PubMed PubMed Central Google Scholar
Miyazaki T, Tsuji M, Hagiwara S, Minamoto T, Ishikawa N, Hirato J, et al. Fatal postpartum hemorrhage in diffuse midline glioma with H3-K27M mutation. Case Rep Obstet Gynecol. 2019;2019:8340437.
PubMed PubMed Central Google Scholar
Karlowee V, Amatya VJ, Takayasu T, Takano M, Yonezawa U, Takeshima Y, et al. Immunostaining of increased expression of enhancer of Zeste homolog 2 (EZH2) in diffuse midline glioma H3K27M-mutant patients with poor survival. Pathobiology. 2019;86(2–3):152–61.
Article CAS PubMed Google Scholar
Giagnacovo M, Antonelli M, Biassoni V, Schiavello E, Warmuth-Metz M, Buttarelli FR, et al. Retrospective analysis on the consistency of MRI features with histological and molecular markers in diffuse intrinsic pontine glioma (DIPG). Childs Nerv Syst. 2020;36(4):697–704.
Chiang J, Diaz AK, Makepeace L, Li X, Han Y, Li Y, et al. Clinical, imaging, and molecular analysis of pediatric pontine tumors lacking characteristic imaging features of DIPG. Acta Neuropathol Commun. 2020;8(1):57.
Article CAS PubMed PubMed Central Google Scholar
Garibotto F, Madia F, Milanaccio C, Verrico A, Piccardo A, Tortora D, et al. Pediatric diffuse midline gliomas H3 K27M-mutant and non-histone mutant midline high-grade gliomas in Neurofibromatosis type 1 in comparison with non-syndromic children: a single-center pilot study. Front Oncol. 2020;10:795.
Article PubMed PubMed Central Google Scholar
Tu JH, Piao YS, Lu DH, Wang LM, Liu L, Bai DY, et al. An adult case of diffuse midline glioma with H3 K27M mutation. Neuropathology. 2020;40(6):627–31.
Article CAS PubMed Google Scholar
Fujioka Y, Hata N, Hatae R, Suzuki SO, Sangatsuda Y, Nakahara Y, et al. A case of diffuse midline glioma, H3 K27M mutant mimicking a hemispheric malignant glioma in an elderly patient. Neuropathology. 2020;40(1):99–103.
Article CAS PubMed Google Scholar
Cheng Y, Bao W, Wu Q. Cerebral hemispheric glioblastoma with PNET-like morphology and histone H3.3 G34 mutation in younger patients: report of three rare cases and diagnostic pitfalls. Indian J Pathol Microbiol. 2020;63(2):262–6.
Baroni LV, Solano-Paez P, Nobre L, Michaeli O, Hawkins C, Laughlin S, et al. Indolent course of brainstem tumors with K27M-H3.3 mutation. Pediatr Blood Cancer. 2020;67(3):e28102.
Babarczy K, Reisz Z, Szabo E, Rajda C, Vecsei L, Bodi I, et al. A longitudinally extensive H3 K27M-mutant diffuse midline glioma in an elderly patient clinically mimicking central nervous system inflammation: a case report. Folia Neuropathol. 2020;58(4):377–85.
Lu VM, Brown DA, Daniels DJ. Rare diffuse intrinsic pontine glioma metastasis throughout the brain and spine. World Neurosurg. 2020;140:301–2.
留言 (0)